Chinese medicine enters the era of plant extraction
In recent years, as botanical medicine, Chinese medicine, and traditional Chinese herbs gradually shine in the international medical field, plant extract products with functional or active characteristics are becoming more and more popular. An independent emerging industry between medicine, food, fine chemicals and agriculture, its development speed even exceeds the growth rate of the pharmaceutical market.
"We live in a world closely related to nature. We have a long history of the development and effective use of these precious resources. This is also the material basis of the development of Chinese pharmacy." Sun Bo has been engaged in plant extraction research for more than 30 years : "Everyone is now promoting big health, and plant extraction is the cornerstone of big health." Along the way, Sun Bo witnessed the industry's trajectory from independent rise to vigorous development.
In recent years, with the popularity of the “Natural No Additive” advertising hot word, consumers ’consumption concepts and consumption trends have changed. Coupled with the vast territory of China, it spans the cold, temperate, subtropical and tropical regions, with rich vegetation and traditional Chinese medicine. The materials are also relatively rich, so Chinese plant extracts have gradually become the main force in the export of Chinese traditional medicine products, accounting for more than 80%! The national policy is actively supported, and the export tax rebate rate is as high as 9%-15%.
However, compared with the popular Chinese herbal extracts, the long-established traditional Chinese medicines have not been recognized internationally. The same principle of Japanese, Korean and Korean prescriptions can be widely popular in the international market. The main crux lies in the Japanese and Korean Hanfang Pharmaceutical, which is somewhere between Chinese and Western medicine. Although it is not as clear as the purity of Western chemical medicines, it does clarify the active ingredients of the medicines. The theory of traditional Chinese medicine emphasizes fusion, and most of them do not have clear medicinal ingredients. They simply emphasize the role of compound medicine, so they have not been recognized internationally.
In the future, it is inevitable for traditional Chinese medicine to enter the international market without clearing the medicinal active ingredients. Plant extraction will help Chinese medicine become more scientific and theoretical.
Looking for chemical products? Let suppliers reach out to you!
2026-07-19
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Treat Acidity: Use medicines with this Pepto Bismol Active Ingredient
-
The battle for Medicine King! With the onslaught of K drug and the setback of Xiomele, the biggest variable in the world's TOP10 drug rankings in 2022 is who?
-
Facing Omicron, Where is the Next 'Special Medicine'?
-
What Are the Medicine that Requires Refrigeration? All You Need Know
-
Short and Breif Analysis of the Lutein
-
Can the Market Continue To Go Higher As The Cost Of Planting Huang Lian Increases?
-
Review of Top 10 Hot Plant Extracts for 2021-Turmeric, Lutein, Stevia Extract, Menthol, Quercetin, Aronia, Ginkgo Biloba Extract, Ashwagandha Ayurvedic Extract, Capsaicin, Saw Palmetto Extract
-
Recently Wanhua Chemical had 1 large transaction with a transaction amount of 4,689,000 Yuan!
-
World's largest cotton spinner successfully develops bio-based PLA, PHBV range of fabrics!
-
China to focus on building quality and efficient TCM service system in next five years
Recommend Reading
-
Moderna to Cut 10 Percent of Staff as COVID Vaccine Sales Plunge Stock Drops 4 Percent
-
Sun Pharma Halts US Expansion Amid 25 Percent Tariff Threat Net Profit Drops 20 Percent
-
Bayer Sets Aside $1.37 Billion for Roundup Lawsuits Raises 2025 Sales Forecast to €48 Billion
-
Trump Pressures 17 Pharma CEOs to Match US Drug Prices with Global Lows September 29 Deadline Set
-
JB Pharma Q1 Net Profit Surges 14 Percent to ₹202 Crore Revenue Hits ₹1094 Crore with 30 Percent EBITDA Margin
-
Entering December, the domestic maleic anhydride market in China continues to decline
-
Soda ash prices in China rose first and then fell in October
-
Weak Demand Sends Acrylonitrile Market into Sharp Decline
-
Fundamentals Slightly Improve, Natural Rubber Market Prices Rise Slightly in August
-
From Fungus to Food: EFSA Greenlights Rhizomucor pusillus Biomass as Safe Novel Ingredient